Sedana Medical AB (SEDANA) Stock Statistics & Valuation Metrics

Sedana Medical AB has a market cap or net worth of kr864.23M. The enterprise value is kr776.21M.

Sedana Medical AB has 99,336,960 shares outstanding. The number of shares has decreased by -2.65% in one year.

Sedana Medical AB’s return on equity (ROE) is -0.07 and return on invested capital (ROIC) is -3.55%.

The current PE Ratio of Sedana Medical AB is ―. Sedana Medical AB’s PEG ratio is -0.04.

In the last 12 months, Sedana Medical AB had revenue of 200.23M and earned -59.24M in profits. Earnings per share was -0.60.

In the last 12 months, operating cash flow was -16.10M and capital expenditures -31.74M, giving a free cash flow of -47.84M billion.

Sedana Medical AB pays an annual dividend of ―, resulting in a dividend yield of ―

Sedana Medical AB upcoming earnings date is Jul 17, 2026, Before Open (Confirmed).

Sedana Medical AB as a current ratio of 3.40, with Debt / Equity ratio of 0.84%

In the past 12 months, Sedana Medical AB has paid 1.98M in taxes.

Sedana Medical AB EV to EBITDA ratio is -92.41, with an EV/FCF ratio of -12.43.

Sedana Medical AB has kr80.68M in cash and marketable securities with kr7.56M in debt, giving a net cash position of kr73.12M billion.

Gross margin is 71.28%, with operating margin of -16.06%, and net profit margin of -29.59%.

The average price target for Sedana Medical AB is ―, which is 11.43% higher than the current price. The consensus rating is ―